{"pmid": "11815513", "sentences": {"sent_1": {"Section": "", "text": "RESEARCH DESIGN AND METHODS : Type 2 diabetic patients ( 30 in the treatment group and 34 in the placebo group ) were recruited for a randomized double - blind placebo - controlled trial for 6 months with the PPAR - gamma agonist rosiglitazone .", "entities": {"entity_1": {"text": "Type 2 diabetic", "class": "Participant", "negation": 0, "UMLS": "C0241863:diabetic,C4085652:Type 2,", "index": 1, "start": 5}, "entity_2": {"text": "placebo", "class": "Intervention", "negation": 0, "UMLS": "C0032042:placebo,", "index": 2, "start": 19}, "entity_3": {"text": "placebo", "class": "Intervention", "negation": 0, "UMLS": "C0032042:placebo,", "index": 3, "start": 30}, "entity_4": {"text": "rosiglitazone", "class": "Intervention", "negation": 0, "UMLS": "C0289313:rosiglitazone,", "index": 4, "start": 43}}, "relations": {}}, "sent_2": {"Section": "", "text": "Blood samples were collected and metabolic variables and adiponectin levels were determined in all patients before initiation of the study .", "entities": {"entity_5": {"text": "Blood samples", "class": "Outcome", "negation": 0, "UMLS": "C0005767:Blood,", "index": 1, "start": 0}, "entity_6": {"text": "metabolic variables", "class": "Outcome", "negation": 0, "UMLS": "", "index": 2, "start": 5}, "entity_7": {"text": "adiponectin levels", "class": "Outcome", "negation": 0, "UMLS": "C2700366:Adiponectin,", "index": 3, "start": 8}}, "relations": {}}}}